Aquinox Pharma (AQXP) Tops Q1 EPS by 21c

Go back to Aquinox Pharma (AQXP) Tops Q1 EPS by 21c

Aquinox Pharmaceuticals Announces First Quarter 2015 Financial Results

May 12, 2015 9:15 AM EDT

VANCOUVER, British Columbia, May 12, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq: AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today provided a corporate update and reported financial results for the first quarter ending March 31, 2015.

... More

Aquinox Pharmaceuticals Announces First Quarter 2015 Financial Results

May 12, 2015 9:15 AM EDT

VANCOUVER, British Columbia, May 12, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq: AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today provided a corporate update and reported financial results for the first quarter ending March 31, 2015.

... More